Term: | vamorolone |
|
Accession: | CHEBI:228304
|
browse the term
|
Definition: | A 3-oxo-Delta(1),Delta(4)-steroid that is pregna-1,4,9(11)-trien-17-ol substituted by oxo, oxo, and hydroxy groups at positions 3, 20, and 21, respectively. It is approved by the FDA for the treatment of patients with Duchenne muscular dystrophy aged 2 years and older. |
Synonyms: | exact_synonym: | 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione |
| related_synonym: | (16alpha)-17,21-dihydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione; 17alpha,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione; Agamree; Formula=C22H28O4; InChI=1S/C22H28O4/c1-13-10-18-16-5-4-14-11-15(24)6-8-20(14,2)17(16)7-9-21(18,3)22(13,26)19(25)12-23/h6-8,11,13,16,18,23,26H,4-5,9-10,12H2,1-3H3/t13-,16-,18+,20+,21+,22+/m1/s1; InChIKey=ZYTXTXAMMDTYDQ-DGEXFFLYSA-N; SMILES=[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)CC=C1[C@@]2([H])CCC2=CC(=O)C=C[C@]12C; VBP 15; VBP15; vamorolona; vamorolonum |
| xref: | CAS:13209-41-1; DrugBank:DB15114; KEGG:D11000; PMCID:PMC9627259; PMID:23498916; PMID:23667681; PMID:24014378; PMID:25392236; PMID:27133900; PMID:28030841; PMID:29524454; PMID:29666400; PMID:29883261; PMID:30120816; PMID:30219580; PMID:30742306; PMID:30745312; PMID:31446438; PMID:31451516; PMID:32434278; PMID:32917814; PMID:32956407; PMID:35076703; PMID:36036925; PMID:36816559; PMID:37440999; PMID:37534133; PMID:37819629; PMID:37927274; PMID:38103149; PMID:38153112; PMID:38335499; Wikipedia:Vamorolone |
|
|